Michigan Medicine

Event

18th Annual Advanced Liver Disease and Liver Transplantation Update (Virtual and In-Person)

presented by Michigan Medicine

12 others would like to attend.

Register Now

Notification icon Friday, April 12, 2024 7:30 AM - 3 PM US/Eastern

Location Icon 21111 Haggerty Rd, Novi, MI 48375, United States

Event info

OVERVIEW

Join this hybrid program in person or virtually. We will update on recent developments in the management of patients with advanced liver disease including recent improvements in the management of metabolic-associated liver disease, GI and Hepatic side effects immunotherapy, and use of TIPS for complications of portal hypertension. In addition, updates on MELD 3.0 in liver transplantation allocation, managing alcohol use disorder, assessment and management of frail LT candidates, how to assess coronary artery disease in patients with cirrhosis, and the use of extacorporeal machine perfusion of donor livers will be provided. After completing this activity, participants will understand and be able to implement in their practice recent developments in the management of patients with advanced liver disease.

TARGET AUDIENCE

This activity is appropriate for:
House Officers, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians, Social Workers

In the fields of:
Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery

LEARNING OBJECTIVES 

At the end of this activity, participant will understand and be able to implement:

  • Newer approaches to the use of weight loss agents and other medications in patients with metabolic associated liver disease
  • Appropriate diagnostic tools and treatment strategies for patients with Immunotherapy related colitis and hepatitis
  • How and when to place a TIPS for cirrhotics with GI bleeding and refractory ascites
  • Use of the MELD 3.0 scoring system in liver transplant candidates
  • How to assess and treat malnutrition and fraility in patients with advanced cirrhosis
  • How to diagnose and treat coronary artery disease and valvular heart disease in patients with cirrhosis
  • Potential use of normothermic and hypothermic perfusion of livers in the transplant setting

ACCREDITATION

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The Michigan State Board of Nursing recognizes the Accreditation Council for Continuing Medical Education (ACCME) as an approved provider of continuing medical education for nurses. CME credits awarded at this program may be applied to the 25 hour relicensing requirements, per Rule 2.a., Michigan State Board of Nursing.

Social Work: This course is approved by NASW-Michigan for 5.5 CE hours.

Transplant Certification: The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 5.75 Category I Continuing Education Points for Transplant Certification (CEPTCs).

 

For more info and to review the full agenda, click the REGISTER NOW button below.

12 others would like to attend.

Register Now


0 Comments
Login to view comments. Click here to Login